Know Cancer

or
forgot password
  • cancer clinical trials in new britain, CT

  • Chemoradiation Therapy and Ipilimumab in Treating Patients With Locally Advanced Cervical Cancer
    The Hospital of Central Connecticut
    New Britain, Connecticut 06050
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage IIIB Cervical Cancer, Stage IVA Cervical Cancer
    An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma

    New Britain, Connecticut 06052
    Relapsed or Refractory Mantle Cell Lymphoma
    Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Leukemia
    Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer
    New Britain General Hospital
    New Britain, Connecticut 06050
    Chronic Myeloproliferative Disorders, Infection, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Vulvar Cancer
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    New Britain General Hospital
    New Britain, Connecticut 06050
    Colorectal Cancer
    Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Gestational Trophoblastic Tumor
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    New Britain General Hospital
    New Britain, Connecticut 06050
    Breast Cancer
    Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk
    George Bray Cancer Center at New Britain General Hospital
    New Britain, Connecticut 06050
    Ovarian Cancer
    Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer

    New Britain, Connecticut 06052
    Renal Cell Carcinoma
    OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
    New Britain General Hospital
    New Britain, Connecticut 06050
    Pancreatic Cancer
    Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients

    New Britain, Connecticut 06052
    Carcinoma, Non-Small-Cell Lung
    Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

    New Britain, Connecticut 06052
    Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Metastases, Neoplasm
    Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer
    New Britain General Hospital
    New Britain, Connecticut 06050
    Pancreatic Cancer
    Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Gestational Trophoblastic Tumor, Neurotoxicity, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    AG-858 in Patients Who Are Cytogenetically Positive After Treatment With Gleevec™

    New Britain, Connecticut 06052
    Leukemia, Myeloid, Chronic
    Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Endometrial Cancer
    Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Cervical Cancer
    Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy
    Connecticut Urological Research at Grove Hill
    New Britain, Connecticut 06052
    Prostate Cancer
    Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Vulvar Cancer
    Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer
    New Britain General Hospital
    New Britain, Connecticut 06050
    Endometrial Cancer
    Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer

    New Britain, Connecticut 06052
    Breast Neoplasms, Neoplasm Metastasis
    Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Cervical Cancer
    GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
    Urology Center of Grove Hill
    New Britain, Connecticut 06052-1395
    Prostate Cancer
    Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy
    Connecticut Urological Research at Grove Hill
    New Britain, Connecticut 06052
    Impotence, Prostate Cancer
    A Phase III Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

    New Britain, Connecticut 06052
    Carcinoma, Hepatocellular
    Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Sarcoma
    Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Sarcoma
    A Long-term Safety Study of Infliximab (Remicade)

    New Britain, Connecticut 06052
    Arthritis, Rheumatoid, Crohn Disease, Psoriasis
    A Study of Single-Agent AT-101 in Men With Hormone Refractory Prostate Cancer

    New Britain, Connecticut 06052
    Hormone Refractory Prostate Cancer
    Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Sarcoma
    Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast Cancer

    New Britain, Connecticut 06052
    Metastatic Breast Cancer
    Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer
    Connecticut Urological Research at Grove Hill
    New Britain, Connecticut 06052
    Bladder Neoplasms
    Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Cervical Cancer
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Cervical Cancer, Endometrial Cancer, Lymphedema, Vulvar Cancer
    Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid Tumors

    New Britain, Connecticut 06052
    Neoplasms
    Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
    BioSante Site 132
    New Britain, Connecticut 06050
    Hypoactive Sexual Desire Disorder
    A Study of Leuprolide to Treat Prostate Cancer
    Site Reference ID/Investigator# 8697
    New Britain, Connecticut 06052
    Prostate Cancer